Author | Herve Tilly, MD, PhD | OncLive

Author | Herve Tilly, MD, PhD

Articles

Dr. Tilly Discusses Study of POLA-R-CHP in DLBCL

July 12, 2017

Video

Herve Tilly, MD, PhD, Centre Henri Becquerel, discusses a study of polatuzumab vedotin combined with rituximab (Rituxan), cyclophosphamide, doxorubicin and prednisone (PLOA-R-CHP) in patients with previously untreated diffuse large B-cell lymphoma.

x